M.L. Swahn

2.0k total citations
35 papers, 1.4k citations indexed

About

M.L. Swahn is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Immunology. According to data from OpenAlex, M.L. Swahn has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 17 papers in Reproductive Medicine and 13 papers in Immunology. Recurrent topics in M.L. Swahn's work include Reproductive System and Pregnancy (13 papers), Ovarian function and disorders (11 papers) and Reproductive Health and Contraception (11 papers). M.L. Swahn is often cited by papers focused on Reproductive System and Pregnancy (13 papers), Ovarian function and disorders (11 papers) and Reproductive Health and Contraception (11 papers). M.L. Swahn collaborates with scholars based in Sweden, Switzerland and Hungary. M.L. Swahn's co-authors include M. Bygdeman, Kristina Gemzell‐Danielsson, Pär Westlund, Peter Svalander, E. Johannisson, G. Ugocsai, B Resch, László Kovács, Markku Seppälä and Lena Marions and has published in prestigious journals such as International Journal of Cancer, Human Reproduction and Fertility and Sterility.

In The Last Decade

M.L. Swahn

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.L. Swahn Sweden 22 738 661 438 413 247 35 1.4k
L. Michael Kettel United States 23 560 0.8× 1.3k 1.9× 362 0.8× 729 1.8× 376 1.5× 38 1.9k
Valerie Ratts United States 20 1.1k 1.5× 998 1.5× 187 0.4× 305 0.7× 104 0.4× 55 1.7k
Kenneth A. Burry United States 20 324 0.4× 702 1.1× 66 0.2× 386 0.9× 251 1.0× 40 1.1k
Keiji Kuroda Japan 25 704 1.0× 1.1k 1.7× 674 1.5× 633 1.5× 86 0.3× 90 1.7k
Ingrid Duijkers Netherlands 23 1.0k 1.4× 805 1.2× 85 0.2× 195 0.5× 165 0.7× 50 1.4k
Gianluca Gennarelli Italy 23 907 1.2× 1.5k 2.2× 217 0.5× 465 1.1× 57 0.2× 74 1.9k
Mehmet Erdem Türkiye 22 546 0.7× 767 1.2× 158 0.4× 331 0.8× 62 0.3× 96 1.3k
D. Barlow United Kingdom 16 180 0.2× 398 0.6× 103 0.2× 281 0.7× 390 1.6× 20 1.2k
Lia A. Bernardi United States 15 555 0.8× 1.1k 1.6× 741 1.7× 760 1.8× 88 0.4× 48 1.6k
Batuhan Özmen Türkiye 20 726 1.0× 856 1.3× 165 0.4× 261 0.6× 51 0.2× 93 1.2k

Countries citing papers authored by M.L. Swahn

Since Specialization
Citations

This map shows the geographic impact of M.L. Swahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.L. Swahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.L. Swahn more than expected).

Fields of papers citing papers by M.L. Swahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.L. Swahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.L. Swahn. The network helps show where M.L. Swahn may publish in the future.

Co-authorship network of co-authors of M.L. Swahn

This figure shows the co-authorship network connecting the top 25 collaborators of M.L. Swahn. A scholar is included among the top collaborators of M.L. Swahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.L. Swahn. M.L. Swahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lundholm, Cecilia, et al.. (2013). Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer. Acta Obstetricia Et Gynecologica Scandinavica. 92(5). 546–554. 52 indexed citations
2.
Melin, A., et al.. (2010). Endometriosis as a prognostic factor for cancer survival. International Journal of Cancer. 129(4). 948–955. 44 indexed citations
3.
Fiala, Christian, M.L. Swahn, Olof Stephansson, & Kristina Gemzell‐Danielsson. (2005). The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13–22 weeks gestation. Human Reproduction. 20(11). 3072–3077. 46 indexed citations
4.
Persson, Bertil, et al.. (2002). Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Research and Clinical Practice. 58(2). 115–121. 66 indexed citations
5.
Marions, Lena, et al.. (1999). Contraceptive efficacy of daily administration of 0.5 mg mifepristone. Human Reproduction. 14(11). 2788–2790. 30 indexed citations
6.
Marions, Lena, Kristina Gemzell‐Danielsson, M.L. Swahn, & M. Bygdeman. (1998). Contraceptive efficacy of low doses of mifepristone. Fertility and Sterility. 70(5). 813–816. 46 indexed citations
7.
Wolff, Kerstin, M.L. Swahn, & Magnus Westgren. (1998). Balloon Catheter for Induction of Labor in Nulliparous Women with Prelabor Rupture of the Membranes at Term. Gynecologic and Obstetric Investigation. 46(1). 1–4. 12 indexed citations
8.
Swahn, M.L., et al.. (1997). Effect of low daily doses of mifepristone on ovarian function and endometrial development. Human Reproduction. 12(1). 124–131. 37 indexed citations
9.
Gemzell‐Danielsson, Kristina, Pär Westlund, E. Johannisson, et al.. (1996). Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Human Reproduction. 11(2). 256–264. 85 indexed citations
10.
Swahn, M.L., et al.. (1996). 3 Contraception with anti-progesterone. Baillière s Clinical Obstetrics and Gynaecology. 10(1). 43–53. 5 indexed citations
11.
Swahn, M.L., Pär Westlund, Elisabeth Johannisson, & M. Bygdeman. (1996). Effect of post‐coital contraceptive methods on the endometrium and the menstrual cycle. Acta Obstetricia Et Gynecologica Scandinavica. 75(8). 738–744. 76 indexed citations
12.
Swahn, M.L., László Kovács, S.Z. Cekan, A.-R. Aedo, & Pär Westlund. (1994). Termination of early pregnancy with ZK 98, 734: pharmacokinetic behaviour and clinical effect. Human Reproduction. 9(1). 57–63. 6 indexed citations
13.
Gemzell‐Danielsson, Kristina, M.L. Swahn, Peter Svalander, & M. Bygdeman. (1993). Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Human Reproduction. 8(6). 870–873. 116 indexed citations
14.
Gottlieb, C., et al.. (1991). Vacuum aspiration for termination of early second trimester pregnancy after treatment with vaginal prostaglandin. Acta Obstetricia Et Gynecologica Scandinavica. 70(1). 41–45. 9 indexed citations
15.
Swahn, M.L., C. Gottlieb, K. Green, & M. Bygdeman. (1990). Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy. Contraception. 41(5). 461–473. 18 indexed citations
16.
Swahn, M.L., et al.. (1989). The effect of tamoxifen on the function and lifespan of the corpus luteum and on subsequent ovarian function. European Journal of Endocrinology. 121(3). 417–425. 8 indexed citations
17.
Swahn, M.L. & M. Bygdeman. (1989). Termination Of Early Pregnancy With Ru 486 (Mifepristone) In Combination With A Prostaglandin Analogue (Sulprostone). Acta Obstetricia Et Gynecologica Scandinavica. 68(4). 293–300. 13 indexed citations
20.
Swahn, M.L., et al.. (1986). Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women. Contraception. 34(5). 469–481. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026